Heart Test Laboratories Stock Buy Hold or Sell Recommendation
| HSCS Stock | USD 2.76 0.09 3.37% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Heart Test Laboratories is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Heart Test Laboratories given historical horizon and risk tolerance towards Heart Test. When Macroaxis issues a 'buy' or 'sell' recommendation for Heart Test Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Heart Test Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Heart and provide practical buy, sell, or hold advice based on investors' constraints. Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Heart |
Execute Heart Test Buy or Sell Advice
The Heart recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Heart Test Laboratories. Macroaxis does not own or have any residual interests in Heart Test Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Heart Test's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Heart Test Trading Alerts and Improvement Suggestions
| Heart Test had very high historical volatility over the last 90 days | |
| Heart Test has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 2.35 K. | |
| Heart Test Laboratories currently holds about 4.27 M in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Heart Test has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Heart Test Laboratories, Inc. Sees Significant Increase in Short Interest |
Heart Test Returns Distribution Density
The distribution of Heart Test's historical returns is an attempt to chart the uncertainty of Heart Test's future price movements. The chart of the probability distribution of Heart Test daily returns describes the distribution of returns around its average expected value. We use Heart Test Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Heart Test returns is essential to provide solid investment advice for Heart Test.
| Mean Return | -0.17 | Value At Risk | -8.97 | Potential Upside | 11.44 | Standard Deviation | 7.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Heart Test historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Heart Stock Institutional Investors
The Heart Test's institutional investors refer to entities that pool money to purchase Heart Test's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Citadel Advisors Llc | 2024-06-30 | 0.0 | Cultivar Capital Inc | 2024-09-30 | 0.0 | Accurate Wealth Management, Llc | 2024-06-30 | 0.0 | Xtx Topco Ltd | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 | First Western Trust Bank | 2024-06-30 | 0.0 | Alphastar Insurance Group Ltd | 2024-06-30 | 0.0 | Fidelity Management And Research Company | 2024-06-30 | 0.0 | Chapin Davis Inc | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-06-30 | 6.4 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.6 K |
Heart Test Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Heart Test or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Heart Test's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Heart stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.45 | |
β | Beta against Dow Jones | 2.22 | |
σ | Overall volatility | 8.03 | |
Ir | Information ratio | -0.04 |
Heart Test Volatility Alert
Heart Test Laboratories is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Heart Test's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Heart Test's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Heart Test Fundamentals Vs Peers
Comparing Heart Test's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Heart Test's direct or indirect competition across all of the common fundamentals between Heart Test and the related equities. This way, we can detect undervalued stocks with similar characteristics as Heart Test or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Heart Test's fundamental indicators could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Heart Test to competition |
| Fundamentals | Heart Test | Peer Average |
| Return On Equity | -2.69 | -0.31 |
| Return On Asset | -0.82 | -0.14 |
| Operating Margin | (379.07) % | (5.51) % |
| Current Valuation | (805.11 K) | 16.62 B |
| Shares Outstanding | 913.82 K | 571.82 M |
| Shares Owned By Insiders | 10.64 % | 10.09 % |
| Shares Owned By Institutions | 1.42 % | 39.21 % |
| Number Of Shares Shorted | 23.08 K | 4.71 M |
| Price To Book | 0.43 X | 9.51 X |
| Price To Sales | 135.60 X | 11.42 X |
| Revenue | 18.6 K | 9.43 B |
| Gross Profit | 2.35 K | 27.38 B |
| EBITDA | (6.16 M) | 3.9 B |
| Net Income | (6.61 M) | 570.98 M |
| Cash And Equivalents | 4.27 M | 2.7 B |
| Cash Per Share | 0.52 X | 5.01 X |
| Total Debt | 1.04 M | 5.32 B |
| Debt To Equity | 0.41 % | 48.70 % |
| Current Ratio | 3.53 X | 2.16 X |
| Book Value Per Share | 6.55 X | 1.93 K |
| Cash Flow From Operations | (6.07 M) | 971.22 M |
| Short Ratio | 0.49 X | 4.00 X |
| Earnings Per Share | (8.41) X | 3.12 X |
| Target Price | 13.5 | |
| Number Of Employees | 15 | 18.84 K |
| Beta | 3.29 | -0.15 |
| Market Capitalization | 2.52 M | 19.03 B |
| Total Asset | 9.5 M | 29.47 B |
| Retained Earnings | (67.36 M) | 9.33 B |
| Working Capital | 5.6 M | 1.48 B |
| Net Asset | 9.5 M |
Note: Acquisition by Andrew Simpson of tradable shares of Heart Test subject to Rule 16b-3 [view details]
Heart Test Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Heart . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Heart Test Buy or Sell Advice
When is the right time to buy or sell Heart Test Laboratories? Buying financial instruments such as Heart Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Heart Test in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Asset Allocation ETFs Thematic Idea Now
Asset Allocation ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Asset Allocation ETFs theme has 144 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Asset Allocation ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.